Developing a new HIV vaccine using nanoparticles
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
This study is working on a new HIV vaccine that uses tiny particles to help deliver important proteins, and it's designed to improve how we prevent HIV, so it could be a great option for people looking for safer and more effective protection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11099643 on NIH RePORTER |
What this research studies
This research focuses on creating and testing a new type of HIV vaccine that uses nanoparticles to deliver the HIV envelope protein. The project involves various stages, including manufacturing the vaccine, conducting preclinical tests, and preparing necessary regulatory documents for human clinical trials. Patients may benefit from this innovative approach as it aims to enhance the effectiveness and safety of HIV prevention strategies. The research will also ensure that the vaccine production follows strict quality control measures.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at high risk for HIV infection or those interested in HIV prevention.
Not a fit: Patients who are already living with HIV or those who are not at risk for HIV infection may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and safer vaccine for preventing HIV infection.
How similar studies have performed: Other research has shown promise in developing nanoparticle-based vaccines for various diseases, indicating potential success for this approach in HIV vaccine development.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.